Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Clinical trial NCT01993186 · COMPLETED
Trial details
- NCT number
- NCT01993186
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-28
- Primary completion
- 2017-09-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.